Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10)

por DENG, WEN, DAI, CHUN-LING, CHEN, JUN-JIANG, KATHAWALA, RISHIL J., SUN, YUE-LI, CHEN, HAI-FAN, FU, LI-WU, CHEN, ZHE-SHENG
Publicado 2013